Skip to main content

Dermatological Complications of Diabetes Mellitus; Allergy to Insulin and Oral Agents

  • Chapter
Principles of Diabetes Mellitus

Abstract

Longstanding diabetes and/or lack of “tight glucose control” over time may result in the development of complications affecting many organ systems, including the skin. In many patients, the first presentation of diabetes may be in the form of dermatitis. Therefore, recognition of skin manifestations of diabetes mellitus is an important aspect of the physical examination. Most cutaneous manifestations of diabetes are attributed either to chronic degenerative changes or to metabolic derangement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 30: 519–31, 1994.

    Article  PubMed  CAS  Google Scholar 

  2. Krakowski A, Covo J, Berlin C. Diabetic scleroderma. Dermatologica, 146: 193–8, 1973.

    Article  PubMed  CAS  Google Scholar 

  3. Rosenbloom AL, Silverstein JM, Lezotte DC, et al. Limited joint mobility in childhood diabetes mellitus indicates increased risk of microvascular disease. N Engl J Med 305: 191–4, 1981.

    Article  PubMed  CAS  Google Scholar 

  4. Meure M, Szeimies RM. Diabetes mellitus and skin diseases. Curr Probl Dermatol 20: 11–23, 1991.

    Google Scholar 

  5. Braverman IM, Ed. Skin signs of systemic disease. WB Saunders, Philadelphia, PA, 654–64, 1981.

    Google Scholar 

  6. Huntley AC. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 7: 427–55, 1982.

    Article  PubMed  CAS  Google Scholar 

  7. Quimby SR, Muller SA, Schroeter AL. The cutaneous immunopathology of necrobiosis lipodica diabeticorum. Arch Dermatol 124: 1364–71, 1998.

    Article  Google Scholar 

  8. Karkavitsas K, et al. Aspirin in the management of necrobiosis lipodica. Acta Derm 62: 183, 1982.

    CAS  Google Scholar 

  9. Freinkel RK. Diabetes mellitus In Fitzpatrick’s Dermatology in General Medicine, 5t Edition. Mc-Graw Hill, New York, p. 1969, 1999.

    Google Scholar 

  10. Dicken CH, Carrington SG, Winkelmann RK. Generalized granuloma annulare. Arch Dermatol 99: 556–63, 1969.

    Article  PubMed  CAS  Google Scholar 

  11. Dabski K, Winkelmann RK. Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol 20: 39–47, 1989.

    Article  PubMed  CAS  Google Scholar 

  12. Muhlemann MF, Williams DR Localized granuloma annulare is associated with insulin-dependent diabetes. Br J Dermatol 111: 325–9, 1984.

    Article  PubMed  CAS  Google Scholar 

  13. Thyresson HN, Doyle JA, Winkelmann RK. Granuloma annulare: histopathologic and direct immunofluorescence study. Acta Denn Venereol (Stockh) 60: 261, 1980.

    CAS  Google Scholar 

  14. Sherry DD, Rothstein RR, Petty RE, et al. Joint contracture preceding insulin-dependent diabetes mellitus. Arthritis Rheum 25: 1362–4, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Starkman HS, Gleason RE, Rand LI, et al. Limited joint mobility of the hands in patients with diabetes mellitus. Ann Rheum Dis 45: 130–5, 1986.

    Article  PubMed  CAS  Google Scholar 

  16. Lieberman LS, Rosenbloom AC, Riley WJ, et al. Reduced skin thickness with pump administration of insulin. N Engl J Med 303: 940–1, 1980.

    PubMed  CAS  Google Scholar 

  17. Weissman K. Skin disorders in diabetes mellitus In Rook/Wilkinson/Ebling’s Textbook of Dermatology. Blackwell Science, Inc: Malden, MA, p. 2676, 1998.

    Google Scholar 

  18. Brik R, Berant M, Vardi P. The Sclerodenna-Like Syndrome of Insulin Dependent Diabetes Mellitus. Diabetes-Metabolism Reviews 7 (2): 120–8, 1991.

    PubMed  CAS  Google Scholar 

  19. Sabin JA. Bacterial infections in diabetes mellitus. Br J Dennatol 91: 481, 1974.

    Google Scholar 

  20. Meurer M, Szeimies RM. Diabetes mellitus and skin diseases. Curr Probl Dermatol 20: 11–23, 1991.

    PubMed  CAS  Google Scholar 

  21. Knight L, Fletcher J. Growth of candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids and diabetes mellitus. J Infect Dis 123: 371–7, 1971.

    Article  PubMed  CAS  Google Scholar 

  22. Oakley WG, Pyke DA, Taylor KW, ed.. Diabetes and its management. Oxford, Blackwell Scientific Publications, Oxford, UK, p.43, 1978.

    Google Scholar 

  23. Calhoun JH, Mader JT. Infection in the diabetic foot. Hosp Pract 30: 81–104, 1992.

    Google Scholar 

  24. Zaky DA, Bentley DW, Lowy K, Betts RF, Douglas RG. Malignant external otitis: a severe form of otitis in diabetic patients. Am J Med 61: 298–302, 1976.

    Article  PubMed  CAS  Google Scholar 

  25. Montes LF, Dobson H, Dodge BG, Knowles WR. Erythrasma and diabetes mellitus. Arch dennatol 99: 674–680, 1969.

    CAS  Google Scholar 

  26. Tomford JW, Whittlesey D, Ellner JJ, Tomashefski JF. Invasive primary cutaneous phycomycosis in diabetic leg ulcers. Arch Surg 115: 770–771, 1980.

    Article  PubMed  CAS  Google Scholar 

  27. Alteras I, Saryt E. Prevalence of pathogenic fungi in the toe-webs and toe-nails of diabetic patients. Mycopathologia 67: 157–159, 1979.

    Article  PubMed  CAS  Google Scholar 

  28. Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol 26: 408–10, 1991.

    Article  Google Scholar 

  29. Basarab T, Munn SE, McGrath J, Jones RR. Bullous diabeticorum: a case report and literature review. Clin Exp Dermatol 20: 218–20 1995.

    Article  PubMed  CAS  Google Scholar 

  30. Bernstein JE, Medenica M, Soltani K, et al. Bullous eruption of diabetes mellitus. Arch Dermatol 115: 324–5, 1975.

    Article  Google Scholar 

  31. Bernstein JE, Levine LE, Medenica MM, et al. Reduced threshold to suction-induced blister formation in insulin-epidermolysis bullosa without immunoreactants. J Am Acad Dermatol 8: 790–1, 1983.

    Article  PubMed  CAS  Google Scholar 

  32. Gilchrest B, Rowe JW, Mihm MC. Bullous dermatosis of hemodialysis. Ann Intern Med 83: 480–3, 1975.

    Article  PubMed  CAS  Google Scholar 

  33. Glynne P et al. Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria? Amer J Kidney Diseases 34: 155–60, 1999.

    Article  CAS  Google Scholar 

  34. Vadoud-Sayedi et al. Treatment of hemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two cases. Br J Dermatol 142: 580–1, 2000.

    Article  Google Scholar 

  35. Rendon MI, Ponciano PD, Sontheimer RD et al. Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol 21: 461–9, 1989.

    Article  PubMed  CAS  Google Scholar 

  36. Sibbald RG, Schachter RK. The skin and diabetes mellitus. Int J Dermatol, 23: 567–584, 1984.

    Article  PubMed  CAS  Google Scholar 

  37. Podolsky S. Lipoatrophic diabetes and leprechaunism, in Podolsky S, Viswanthan M, Eds. The Spectrum of the diabetic syndromes. New York, Raven Press, pp. 335–352, 1980.

    Google Scholar 

  38. Louis LH, Conn VW, Minick MC. Lipoatrophic diabetes: isolation and characterization of insulin anatagonist from the urine. Metabolism 12: 867–886, 1963.

    PubMed  CAS  Google Scholar 

  39. Lawrence RD. Lipodystrophy and hepatomegaly with diabetes, lipemia, and other metabolic disturbances. Lancet 250: 724–731, 1946.

    Article  Google Scholar 

  40. Dunnigan MG. Unusual clinical manifestations of diabetes mellitus. Practitioner 222: 321–330, 1979.

    PubMed  CAS  Google Scholar 

  41. Mabry CC, Hollingsworth DR, Upton CV and Corbin A. Pituitary-hypothalamic dysfunction in generalized lipodystrophy. J Pediatrics 82 (4): 625–33, 1973.

    Article  CAS  Google Scholar 

  42. Oseid S, Beck-Nielsen H, Pederson O, Sovik O. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med 296: 245–248, 1977.

    Article  PubMed  CAS  Google Scholar 

  43. Jelinek, JE. The skin in diabetes mellitus: cutaneous manifestations, complications and associations. In Yearbook of dermatology, 1970. Chicago, Year Book Medical Publishers, Inc., pp. 5–35, 1970.

    Google Scholar 

  44. Hoerer E, Dreyfuss F, Herzberg M. Carotenemia, skin color and diabetes mellitus. Acta Diabetol Lat 12: 202–7, 1975.

    Article  PubMed  CAS  Google Scholar 

  45. Rapini RP, Herbert AA, Drucker CR. Acquired perforating dermatosis: evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol 125: 1074–8, 1989.

    Article  PubMed  CAS  Google Scholar 

  46. Lithner F. Purpura, pigmentation and yellow nails of the lower extremities in diabetes. Acta Med Scand 199: 203–8, 1976.

    Article  PubMed  CAS  Google Scholar 

  47. Halevy S, Feuerman EJ. Abnormal glucose tolerance associated with lichen planus. Acta Derm Venereol 59: 167–70, 1979.

    PubMed  CAS  Google Scholar 

  48. Albrecht M, Banoczy J, Dinya E, et al. Occurrence of oral leukoplakia and lichen planus in diabetes mellitus. J Oral Pathol 21: 364–6, 1992.

    Article  CAS  Google Scholar 

  49. Muller SA. Dermatologic disorders associated with diabetes mellitus. Mayo Clin Proc 41: 689–703, 1966.

    PubMed  CAS  Google Scholar 

  50. Pinkus H, Mehregan AH. A guide to dermatohistopathology. New York, Appleton-Century-Crofts, p. 417, 1976.

    Google Scholar 

  51. Chevrant-Breton J, Simon M, Bourel M, Ferrand B. Cutaneous manifestations of idiopathic hemochromatosis. Arch Dermatol 113: 161–5, 1977.

    Article  PubMed  CAS  Google Scholar 

  52. Kahana M, Grossman E, Feinstein A, et al. Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol 67: 175–7, 1986.

    Google Scholar 

  53. Bleich HL, Boro ES. Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis. N Engl J Med 295: 1416–20, 1976.

    Article  Google Scholar 

  54. Levy DM, Teenghi G, GU XH. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 35: 889–97, 1992.

    Article  PubMed  CAS  Google Scholar 

  55. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326: 1250–6, 1992.

    Article  PubMed  CAS  Google Scholar 

  56. Ellenberg M. Diabetic Foot. NY State J Med, 73: 2778–2781, 1973.

    CAS  Google Scholar 

  57. Lippman HI, Perotto A, Farrar R. The neuropathic foot of the diabetic. Bull NY Acad Med 52: 1159–1178, 1976.

    Google Scholar 

  58. Editorial. Diabetic foot ulcers. Lancet 1: 232–233, 1977.

    Google Scholar 

  59. Ajam Z, Barton SP, Marks R. Characterization of abnormalities in the cutaneous microvasculature of diabetic subjects. Br J Dermatol 107 (suppl 22): 22–3, 1982.

    Google Scholar 

  60. Huntley AC. Cutaneous manifestations of diabetes mellitus. Dermatol Clin 7: 531–46, 1989.

    PubMed  CAS  Google Scholar 

  61. Grunfeld C. Diabetic foot ulcers: etiology, treatment and prevention. Adv Intern Med 37: 103–32, 1991.

    Google Scholar 

  62. Ditzel J. Functional microangiopathy in diabetes mellitus. Diabetes 17: 388397, 1968.

    Google Scholar 

  63. Landau J, Davis E. The small blood vessels of the conjunctiva and nailbed in diabetes mellitus. Lancet 2: 731–734, 1960.

    Article  PubMed  CAS  Google Scholar 

  64. Lithner F, Hietala SO. Skeletal lesions of the feet in diabetics and their relationship to cutaneous erythema with or without necrosis of the feet. Acta Med Scand 200: 155–161, 1976.

    Article  PubMed  CAS  Google Scholar 

  65. Fitzpatrick TB et al. Color atlas and synopsis of clinical dermatology. New York, McGraw-Hill, pp. 417–8, 2001.

    Google Scholar 

  66. Feingold KR, Siperstein MD. Diabetic vascular disease. Adv Intern Med; 31: 309–40, 1986.

    PubMed  CAS  Google Scholar 

  67. Haroon TS. Diabetes and skin: a review. Scott Med J 19: 257–67, 1974.

    PubMed  CAS  Google Scholar 

  68. Jegasothy, BV. Allergic reactions to insulin. Int J Dermatol, 19: 139–41, 1980.

    Article  PubMed  CAS  Google Scholar 

  69. Galloway JA, Davidson JK. Clinical use of insulin, in Rifkin H, Raskin P, Eds. Diabetes mellitus. Bowie, RJ Brady Co., vol 5, pp 117–27, 1981.

    Google Scholar 

  70. Feinglos MN, Jegasothy BV. “Insulin” allergy due to zinc. Lancet 1: 122–24, 1979.

    Article  PubMed  CAS  Google Scholar 

  71. Galloway, JA, Bressler R. Insulin treatment in diabetes. Med Clin North Am 62: 663–80, 1978.

    PubMed  CAS  Google Scholar 

  72. Grammer LC, Metzger BE, Patterson R. Cutaneous allergy to human (recombinant DNA) insulin. JAMA 251: 1459–60, 1984.

    Article  PubMed  CAS  Google Scholar 

  73. Edidin DV. Cutaneous manifestations of diabetes mellitus in children. Pediatr Dermatol 2: 161–179, 1985.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Marmur, E.S., Pasternack, F.R., Varghese, M.C. (2004). Dermatological Complications of Diabetes Mellitus; Allergy to Insulin and Oral Agents. In: Poretsky, L. (eds) Principles of Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6260-0_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6260-0_26

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6262-4

  • Online ISBN: 978-1-4757-6260-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics